An innovative clinical trial examining whether robotic companion pets can improve the outcomes of hospitalized older adults with dementia has delivered meaningful results that have far-reaching ...
Zacks Investment Research on MSN
Zoetis gears up to report Q4 earnings: Here's what to expect
Zoetis, Inc. ZTS is expected to beat expectations when it reports its fourth-quarter 2025 earnings on Feb. 12, 2026, before ...
A new CRISPR-based one-off procedure that lowers "bad" cholesterol is expected to enter Phase I human trial in 2026. If successful, it could be the first approved genetic-silencing method on the ...
The FDA is freeing Intellia Therapeutics' CRISPR therapy from one of two clinical holds, allowing a phase 3 study to resume after a grade 4 liver event and subsequent patient death was reported in the ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Imagine a world where your furry best friend could tell you exactly what they're thinking. A growing number of dog owners claim this is already happening, thanks to innovative word buttons that seem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results